RE: Afternoon all27 Nov 2025 17:27
Pumpky, youโre talking like someone who hasnโt even read the RNS.
The Midkine spinout is confirmed. ROQ holders get the new shares and thatโs already stated by the company. Spinout shares list on a market that is how a spinout works. Saying theyโre unsellable just shows you donโt understand the process. Bringing up the old 1.7p placing has zero relevance to an RTO valuation. Biotech RTOs donโt price off historic placings. Everyone knows that. Itโs a completely different valuation method.
The reality is simple ROQ is lined up for a much larger valuation through the RTO, and holders receive the Midkine shares on top. Thatโs the genuine upside here.
If youโre going to pick holes, at least get the basics right.